- Home
- ITRM vs LTRN Comparison
ITRM vs LTRN Comparison
Compare ITRM & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- LTRN
- Stock Information
- Founded
- ITRM 2015
- LTRN 2013
- Country
- ITRM Ireland
- LTRN United States
- Employees
- ITRM N/A
- LTRN N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- ITRM Health Care
- LTRN Health Care
- Exchange
- ITRM Nasdaq
- LTRN Nasdaq
- Market Cap
- ITRM 40.0M
- LTRN 36.0M
- IPO Year
- ITRM 2018
- LTRN 2020
- Fundamental
- Price
- ITRM $0.68
- LTRN $3.83
- Analyst Decision
- ITRM Strong Buy
- LTRN Strong Buy
- Analyst Count
- ITRM 2
- LTRN 1
- Target Price
- ITRM $7.00
- LTRN $25.00
- AVG Volume (30 Days)
- ITRM 749.8K
- LTRN 75.1K
- Earning Date
- ITRM 11-13-2025
- LTRN 11-06-2025
- Dividend Yield
- ITRM N/A
- LTRN N/A
- EPS Growth
- ITRM N/A
- LTRN N/A
- EPS
- ITRM N/A
- LTRN N/A
- Revenue
- ITRM N/A
- LTRN N/A
- Revenue This Year
- ITRM N/A
- LTRN N/A
- Revenue Next Year
- ITRM $249.35
- LTRN N/A
- P/E Ratio
- ITRM N/A
- LTRN N/A
- Revenue Growth
- ITRM N/A
- LTRN N/A
- 52 Week Low
- ITRM $0.61
- LTRN $2.55
- 52 Week High
- ITRM $3.02
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- ITRM 43.17
- LTRN 39.82
- Support Level
- ITRM $0.61
- LTRN $3.74
- Resistance Level
- ITRM $0.76
- LTRN $4.26
- Average True Range (ATR)
- ITRM 0.05
- LTRN 0.34
- MACD
- ITRM 0.01
- LTRN -0.06
- Stochastic Oscillator
- ITRM 49.65
- LTRN 9.35
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.